Journal
JOURNAL OF BUSINESS ECONOMICS AND MANAGEMENT
Volume 13, Issue 1, Pages 5-28Publisher
VILNIUS GEDIMINAS TECH UNIV
DOI: 10.3846/16111699.2011.620165
Keywords
competitive-strategy selection; fuzzy analytic network process (FANP); foreign direct investment (FDI); multinational biotech pharmaceutical enterprises
Ask authors/readers for more resources
This study explores efforts to identify the most appropriate competitive strategy relative to multinational biotech pharmaceutical enterprises' strategy selection. The research uses the analytic network process (ANP) technique combining both qualitative and quantitative information to construct a hierarchical model involving interactions among various criteria for competitive strategy selection, and also introduces fuzzy logic to eliminate vagueness, subjectivity, and imprecision stemming from human judgment. The most important finding shows that the most suitable competitive strategy for multinational enterprises (MNEs) is innovative-focus strategy. Also, the weighted calculations present the three most important criteria affecting the competitive strategy of foreign direct investment (FDI): collaboration with local partners, governmental rules and regulations and high-quality research personnel with R & D capability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available